These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26801626)

  • 1. Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractions.
    Korolenko TA; Johnston TP; Tuzikov FV; Tuzikova NA; Pupyshev AB; Spiridonov VK; Goncharova NV; Maiborodin IV; Zhukova NA
    Lipids Health Dis; 2016 Jan; 15():16. PubMed ID: 26801626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart.
    Korolenko TA; Tuzikov FV; Johnston TP; Tuzikova NA; Kisarova YA; Zhanaeva SY; Alexeenko TV; Zhukova NA; Brak IV; Spiridonov VK; Filjushina EE; Cherkanova MS; Monoszon AA
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1456-68. PubMed ID: 23181274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.
    Korolenko TA; Tuzikov FV; Cherkanova MS; Johnston TP; Tuzikova NA; Loginova VM; Filjushina EE; Kaledin VI
    Can J Physiol Pharmacol; 2012 Feb; 90(2):141-53. PubMed ID: 22320860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-407-induced Mouse Model of Dose-controlled Hyperlipidemia and Atherosclerosis: 25 Years Later.
    Johnston TP; Korolenko TA; Sahebkar A
    J Cardiovasc Pharmacol; 2017 Nov; 70(5):339-352. PubMed ID: 28777256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet.
    Lai P; Du JR; Zhang MX; Kuang X; Li YJ; Chen YS; He Y
    J Ethnopharmacol; 2011 Oct; 137(3):1061-6. PubMed ID: 21718773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cystatin C and chitotriosidase in acute P-407 induced dyslipidemia: Can they serve as potential early biomarkers for atherosclerosis?
    Korolenko TA; Pisareva EE; Filyushina EE; Johnston TP; Machova E
    Exp Toxicol Pathol; 2015 Sep; 67(9):459-66. PubMed ID: 26129870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative characteristics of lipemia models induced by injections of Triton WR-1339 and poloxamer 407 in mice.
    Loginova VM; Tuzikov FV; Tuzikova NA; Korolenko TA
    Bull Exp Biol Med; 2013 Jun; 155(2):284-7. PubMed ID: 24131010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
    Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
    J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of poloxamer 407 administration on the serum lipids profile, anxiety level and protease activity in the heart and liver of mice.
    Korolenko TA; Johnston TP; Dubrovina NI; Kisarova YA; Zhanaeva SY; Cherkanova MS; Filjushina EE; Alexeenko TV; Machova E; Zhukova NA
    Interdiscip Toxicol; 2013 Mar; 6(1):18-25. PubMed ID: 24170975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidemic Effect of Mannan in Mice with Acute Lipemia Induced by Poloxamer 407.
    Goncharova NV; Khrapova MV; Pupyshev AB; Korolenko ET; Nešéáková Z; Korolenko TA
    Bull Exp Biol Med; 2016 Nov; 162(1):18-22. PubMed ID: 27878733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of Macrophages Modifies Serum Lipid Profile in Hyperlipidemia.
    Goncharova NV; Pupyshev AB; Filyushina EE; Loktev KV; Korolenko ETs; Lushnikova EL; Molodykh OP; Korolenko TA; Churin BV
    Bull Exp Biol Med; 2016 Mar; 160(5):617-21. PubMed ID: 27021105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
    Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the hypolipidaemic effects of a new polysaccharide, mannan Candida albicans serotype A, and atorvastatin in mice with poloxamer 407-induced hyperlipidaemia.
    Korolenko T; Johnston TP; Lykov AP; Shintyapina AB; Khrapova MV; Goncharova NV; Korolenko E; Bgatova NP; Machova E; Nescakova Z; Sakhno LV
    J Pharm Pharmacol; 2016 Dec; 68(12):1516-1526. PubMed ID: 27704584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of changes in serum chitotriosidase activity in mice under conditions of hyperlipidemia and lipid-lowering effect of carboxymethylated (1-3)-β-D-glycan.
    Pisareva EE; Goncharova IA; Tuzikov FV; Goncharova NV; Makhova E; Korolenko TA
    Bull Exp Biol Med; 2014 Sep; 157(5):555-9. PubMed ID: 25257411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of pretreatment with quercetin as assessed by acetylcholinesterase assay and behavioral testing in poloxamer-407 induced hyperlipidemic rats.
    Braun JBS; Ruchel JB; Adefegha SA; Coelho APV; Trelles KB; Signor C; Rubin MA; Oliveira JS; Dornelles GL; de Andrade CM; Castilhos LG; Leal DBR
    Biomed Pharmacother; 2017 Apr; 88():1054-1063. PubMed ID: 28192878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP; Zhou X
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models.
    Heinonen SE; Kivelä AM; Huusko J; Dijkstra MH; Gurzeler E; Mäkinen PI; Leppänen P; Olkkonen VM; Eriksson U; Jauhiainen M; Ylä-Herttuala S
    Cardiovasc Res; 2013 Sep; 99(4):716-23. PubMed ID: 23756254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.